1. Home
  2. CSIQ vs PCRX Comparison

CSIQ vs PCRX Comparison

Compare CSIQ & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Canadian Solar Inc. (ON)

CSIQ

Canadian Solar Inc. (ON)

HOLD

Current Price

$12.80

Market Cap

906.4M

Sector

Technology

ML Signal

HOLD

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$25.42

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CSIQ
PCRX
Founded
2001
2006
Country
Canada
United States
Employees
N/A
N/A
Industry
Semiconductors
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
906.4M
1.1B
IPO Year
2006
2010

Fundamental Metrics

Financial Performance
Metric
CSIQ
PCRX
Price
$12.80
$25.42
Analyst Decision
Hold
Strong Buy
Analyst Count
10
4
Target Price
$17.36
$30.25
AVG Volume (30 Days)
1.8M
416.5K
Earning Date
05-14-2026
04-30-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
107.44
EPS
N/A
0.19
Revenue
N/A
$541,533,000.00
Revenue This Year
$23.61
$6.78
Revenue Next Year
$13.90
$8.54
P/E Ratio
N/A
$136.21
Revenue Growth
N/A
26.04
52 Week Low
$10.74
$18.80
52 Week High
$34.59
$27.66

Technical Indicators

Market Signals
Indicator
CSIQ
PCRX
Relative Strength Index (RSI) 40.18 48.87
Support Level $12.35 $24.61
Resistance Level $16.48 $26.93
Average True Range (ATR) 0.77 0.66
MACD -0.04 0.04
Stochastic Oscillator 26.16 52.92

Price Performance

Historical Comparison
CSIQ
PCRX

About CSIQ Canadian Solar Inc. (ON)

Canadian Solar Inc is a Canadian solar technology and renewable energy company. It is a manufacturer of solar photovoltaic modules, a provider of battery energy storage solutions, and a developer of utility-scale solar power and battery energy storage projects. The company is organized in two segments: Manufacturing segment, comprising CS PowerTech, which focuses on manufacturing and sales of solar products, battery energy storage products, and other power technology products for the U.S. market and CSI Solar, which serves all other world-wide markets; and Recurrent Energy segment, which focuses on solar power and battery storage project development, asset sales, power services, and electricity revenue from its operating portfolio. It derives maximum revenue from Manufacturing segment.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: